Manufacturer with High Purity and Stable Quality
Commercial Supply Favipiravir (CAS: 259793-96-9) and Related Intermediates:
Favipiravir CAS: 259793-96-9
3,6-Dichloropyrazine-2-carbonitrile CAS: 356783-16-9
3,6-Difluoropyrazine-2-carbonitrile CAS: 356783-28-3
6-Bromo-3-hydroxypyrazine-2-carboxamide CAS: 259793-88-9
3-Hydroxypyrazine-2-Carboxamide CAS: 55321-99-8
2-Aminopropanediamide CAS: 62009-47-6
Diethyl Aminomalonate Hydrochloride CAS: 13433-00-6
| Chemical Name |
Diethyl Aminomalonate Hydrochloride |
| Synonyms |
Aminomalonic Acid Diethyl Ester Hydrochloride |
| CAS Number |
13433-00-6 |
| CAT Number |
RF-PI225 |
| Stock Status |
In Stock, Production Scale Up to Tons |
| Molecular Formula |
C7H14ClNO4 |
| Molecular Weight |
211.64 |
| Brand |
Ruifu Chemical |
| Item |
Specifications |
| Appearance |
White or Off-White Crystalline Powder |
| Melting Point |
162.0~168.0℃ |
| Loss on Drying |
≤0.50% |
| Purity |
≥99.0% |
| Test Standard |
Enterprise Standard |
| Usage |
Pharmaceutical Intermediates; Favipiravir (CAS: 259793-96-9) Intermediate |
Package: Bottle, Aluminum foil bag, Cardboard drum, 25kg/Drum, or according to customer's requirement.
Storage Condition: Store in sealed containers at cool and dry place; Protect from light, moisture and pest infestation.
Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer and supplier of Diethyl Aminomalonate Hydrochloride (CAS: 13433-00-6) with high quality, widely used in organic synthesis, synthesis of pharmaceutical intermediates and Active Pharmaceutical Ingredient (API) synthesis.
Diethyl Aminomalonate Hydrochloride (CAS: 13433-00-6) is used as an intermediate of Favipiravir (CAS: 259793-96-9) in the treatment of patients with COVID-19 recommended by WHO. Favipiravir is is one of the 5 compounds recommended by WHO for the investigation of treatment of COVID-19.
Diethyl Aminomalonate Hydrochloride is used as a reagent in the synthesis N-(aminopropyl)-N-aroylaminopropyl-substituted thiazolo[5,4-d]pyrimidinones and its analogs as kinesin spindle protein inhibitors and potential anticancer agents.